| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $63.74 ▲ +2.02% | Yesterday | $62.48 • 0.00% | Tomorrow's Tarsus Pharmaceuticals Inc. Common Stock (TARS) setup is anchored to $62.48 and targets $63.74 (+2.02%). The near-term read is upside; watch $64.98 / $59.98 because daily realized volatility is about 4.16%. |
Tomorrow's Tarsus Pharmaceuticals Inc. Common Stock (TARS) setup is anchored to $62.48 and targets $63.74 (+2.02%). The near-term read is upside; watch $64.98 / $59.98 because daily realized volatility is about 4.16%. | ||||
| Week | $62.38 ▼ -0.16% | Last Week | $62.48 • 0.00% | The 7-day Tarsus Pharmaceuticals Inc. Common Stock model moves from $62.48 to $62.38 (-0.16%). It gives downside momentum context for this stock, so breaks around $64.98 / $59.98 matter more than a single tick. |
The 7-day Tarsus Pharmaceuticals Inc. Common Stock model moves from $62.48 to $62.38 (-0.16%). It gives downside momentum context for this stock, so breaks around $64.98 / $59.98 matter more than a single tick. | ||||
| Month | $60.01 ▼ -3.95% | Last Month | $62.48 • 0.00% | The 1-month Tarsus Pharmaceuticals Inc. Common Stock target is $60.01 (-3.95%), compared with the live reference near $62.48. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Tarsus Pharmaceuticals Inc. Common Stock target is $60.01 (-3.95%), compared with the live reference near $62.48. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $56.55 ▼ -9.49% | Last Year | $62.48 • 0.00% | The 1-year Tarsus Pharmaceuticals Inc. Common Stock scenario points to $56.55 (-9.49%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Tarsus Pharmaceuticals Inc. Common Stock scenario points to $56.55 (-9.49%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $48.61 ▼ -22.20% | 5 Years Ago | $62.48 • 0.00% | The 5-year Tarsus Pharmaceuticals Inc. Common Stock view is $48.61 (-22.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Tarsus Pharmaceuticals Inc. Common Stock view is $48.61 (-22.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| RSI 14 | 40.6 | Bearish |
| MACD | 0.05 | Bullish |
| SMA 50 | $62.26 | Above |
| SMA 200 | $62.33 | Mid |
| EMA 20 | $62.13 | Above |
| Opening Price | $62.48 | Start Date | 2021-05-17 |
| Day Range | $60.79 – $64.17 | Market Cap | $2.75B |
| Monthly Range | $57.01 – $65.60 | 24h Volume | n/a |
| 90D Range | $56.02 – $66.64 | Circulating | n/a |
| 52W Range | $51.61 – $67.94 | Max Supply | n/a |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.